Verus Capital Partners, LLC Abb Vie Inc. Transaction History

Verus Capital Partners, LLC

$1.08 Billion
Q3 2024

A detailed history of Verus Capital Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Verus Capital Partners, LLC holds 64,285 shares of ABBV stock, worth $10.6 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares

64,285

Previous 64,954 1.03%

Holding current value

$10.6 Million

Previous $11.1 Million 13.96%

% of portfolio

1.17%

Previous 1.09%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$163.84 - $199.33 $109,608 - $133,351	-669 Reduced 1.03%	64,285 $12.7 Million
Q2 2024 Aug 01, 2024	BUY	$154.79 - $180.76 $48,604 - $56,758	314 Added 0.49%	64,954 $11.1 Million
Q1 2024 May 07, 2024	BUY	$159.82 - $182.1 $158,221 - $180,279	990 Added 1.56%	64,640 $11.8 Million
Q4 2023 Feb 09, 2024	SELL	$137.6 - $154.97 $198,832 - $223,931	-1,445 Reduced 2.22%	63,650 $9.86 Million
Q3 2023 Nov 01, 2023	SELL	$133.59 - $154.65 $1.54 Million - $1.78 Million	-11,540 Reduced 15.06%	65,095 $9.7 Million
Q2 2023 Jul 31, 2023	SELL	$132.51 - $164.9 $1.64 Million - $2.05 Million	-12,402 Reduced 13.93%	76,635 $10.3 Million
Q1 2023 May 09, 2023	BUY	$144.61 - $166.54 $911,043 - $1.05 Million	6,300 Added 7.61%	89,037 $14.2 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $697,497 - $836,482	-5,043 Reduced 5.75%	82,737 $13.4 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $3.3 Million - $3.79 Million	24,606 Added 38.95%	87,780 $11.8 Million
Q2 2022 Aug 09, 2022	SELL	$137.62 - $174.96 $4.76 Million - $6.05 Million	-34,590 Reduced 35.38%	63,174 $14.6 Million
Q1 2022 Aug 09, 2022	BUY	$131.98 - $163.75 $10.2 Million - $12.7 Million	77,482 Added 382.02%	97,764 $15 Million
Q1 2020 May 26, 2020	BUY	$64.5 - $97.79 $242,391 - $367,494	3,758 Added 22.74%	20,282 $1.55 Million
Q4 2019 Feb 27, 2020	BUY	$72.13 - $90.25 $1.19 Million - $1.49 Million	16,524 New	16,524 $1.46 Million

Others Institutions Holding ABBV

# of Institutions

3,841

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $292B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verus Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verus Capital Partners, LLC with notifications on news.

Account

Verus Capital Partners, LLC Abb Vie Inc. Transaction History